Tag: Ironwood Pharmaceuticals

January 26, 2017 Off

FDA OK’s Ironwood/Allergan’s constipation drug

Ironwood Pharmaceuticals and Allergan have won U.S. Food and Drug Administration’s (FDA) approval for 72 mcg dose of Linzess (linaclotide) for the treatment of chronic idiopathic constipation (CIC) in adult patients.

October 27, 2015 Off

Allergan Acquires Rights To Ironwood’s Constella

By Dino Mustafić

Allergan plc and Ironwood Pharmaceuticals, Inc. have announced that Allergan has acquired rights to Constella (linaclotide) in the European Union, Switzerland, Turkey and the Commonwealth of Independent States from Almirall, S.A. and has also reacquired rights to Linzess (linaclotide) in Mexico from Almirall.